Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 8 of 68

Pre-close trading update confirms good progress against 2018 goals

Published03/01/2019

Global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio

Published08/11/2018

Rising to the challenge of developing inhaled generic medicines

Published26/09/2018

Vectura Group Interim Results for H1 2018

Published11/09/2018

Fundraising for AsthmaUK

Published06/07/2018

Bringing nebuliser device and formulation together

Published05/07/2018

New product creation – from paper to market

Published04/07/2018

Generic programmes

Published03/07/2018

Displaying 8 of 68